Schedule 13G ownership disclosure
Century Therapeutics, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 15673T100
Event date: 2026-01-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Commodore Capital LP
Shares: 13,043,478.00 · Class: 7.1%
- Commodore Capital Master LP
Shares: 13,043,478.00 · Class: 7.1%
- Robert Egen Atkinson
Shares: 13,043,478.00 · Class: 7.1%
- Michael Kramarz
Shares: 13,043,478.00 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001831942-26-000002
- Form type
- SCHEDULE 13G
- Filer
- Century Therapeutics, Inc.
- CIK
- CIK 1850119
- Filed
- Jan 16, 2026
- Reporting period
- Jan 09, 2026
- Description
- Schedule 13G beneficial ownership